Soergel David
SEC CIK 1591475 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Chief Medical Off | 10.0K | — | $952.0K | 4 | 2025-05-15 | 2026-06-01 |
Most active insiders at MDGL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | FRIEDMAN PAUL A | Dir | — | $26.66M |
| 2 | Taub Rebecca | Dir | — | $21.68M |
| 3 | Sibold William John | Pres, CEO, Dir | — | $10.48M |
| 4 | BATE KENNETH | Dir | — | $8.03M |
| 5 | Levy Richard S | Dir | — | $7.36M |
| 6 | Dier Mardi | EVP, CFO | — | $3.77M |
| 7 | Huntsman Carole | Chief Commercial Off | — | $1.71M |
| 8 | Soergel David | Chief Medical Off | — | $952.0K |
| 9 | Kelley Shannon T | GC | — | $841.6K |
| 10 | Thakkar Rita | CAO | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-01 19:49 | 2026-06-01 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Soergel David | Chief Medical Off | S - Sale | $495.74 | -1,042 | 10.0K | -9% | -$516.6K |
| 2026-05-18 17:36 | 2026-05-18 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Soergel David | Chief Medical Off | S - Sale | $515.90 | -844 | 11.1K | -7% | -$435.4K | |
| D | 2026-03-06 | 2026-03-04 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Soergel David | Chief Medical Off | A - Grant | $0.00 | +4,374 | 11.9K | +58% | $0 |
| D | 2025-05-16 | 2025-05-15 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Soergel David | Chief Medical Off | A - Grant | $0.00 | +7,545 | 7,545 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations